These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37284490)

  • 41. Turning the promise of multipurpose prevention technologies into a market reality: a commentary.
    Dam A; Schueller J; Peine KJ; Mason J; Dorward E; Vij A
    Front Reprod Health; 2023; 5():1181043. PubMed ID: 38023534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Etonogestrel implant use in women primarily choosing a combined oral contraceptive pill: A proof-of-concept trial.
    Chen MJ; Hsia JK; Creinin MD
    Contraception; 2018 Jun; 97(6):533-537. PubMed ID: 29496473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrating PrEP delivery in public health family planning clinics: a protocol for a pragmatic stepped wedge cluster randomized trial in Kenya.
    Mugwanya KK; Matemo D; Scoville CW; Beima-Sofie KM; Meisner A; Onyango D; Mugambi M; Feutz E; Grabow C; Barnabas R; Weiner B; Baeten JM; Kinuthia J;
    Implement Sci Commun; 2021 Dec; 2(1):135. PubMed ID: 34895357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimizing the pipeline of multipurpose prevention technologies: opportunities across women's reproductive lifespans.
    Bershteyn A; Resar D; Kim HY; Platais I; Mullick S
    Front Reprod Health; 2023; 5():1169110. PubMed ID: 37325241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exploring technology-based interventions to improve oral contraceptive pill adherence: a cross-sectional survey.
    Flynn A; Galvao R; Joslin I; McAllister A; Koelper NC; Sonalkar S
    Eur J Contracept Reprod Health Care; 2023 Jun; 28(3):173-176. PubMed ID: 37013727
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microarray patch for HIV prevention and as a multipurpose prevention technology to prevent HIV and unplanned pregnancy: an assessment of potential acceptability, usability, and programmatic fit in Kenya.
    Gachigua SG; Karuga R; Ngunjiri A; Jarrahian C; Coffey PS; Kilbourne-Brook M; Otiso L
    Front Reprod Health; 2023; 5():1125159. PubMed ID: 37168102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survey of general practitioner instructions to oral contraceptive users.
    Kovacs GT; Murtagh J
    Aust Fam Physician; 1994 May; 23(5):915-8. PubMed ID: 8037631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Strategies to improve adherence and continuation of shorter-term hormonal methods of contraception.
    Mack N; Crawford TJ; Guise JM; Chen M; Grey TW; Feldblum PJ; Stockton LL; Gallo MF
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD004317. PubMed ID: 31013349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral pre-exposure prophylaxis uptake, adherence, and adverse events among South African men who have sex with men and transgender women.
    Bekker LG; Giovenco D; Baral S; Dominguez K; Valencia R; Sanchez T; McNaghten AD; Zahn R; Yah CS; Sokhela Z; Kaplan R; Phaswana-Mafuya RN; Beyrer C; Sullivan PS
    South Afr J HIV Med; 2022; 23(1):1405. PubMed ID: 36479416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Process evaluation of PrEP implementation in Kenya: adaptation of practices and contextual modifications in public HIV care clinics.
    Irungu EM; Odoyo J; Wamoni E; Bukusi EA; Mugo NR; Ngure K; Morton JF; Mugwanya KK; Baeten JM; O'Malley G;
    J Int AIDS Soc; 2021 Sep; 24(9):e25799. PubMed ID: 34496148
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Managing menstrual disturbances.
    Barnett B
    Netw Res Triangle Park N C; 1995 Jun; 15(4):8. PubMed ID: 12289833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Women's attitudes to withdrawal bleeding and their knowledge and beliefs about the oral contraceptive pill.
    Rutter W; Knight C; Vizzard J; Mira M; Abraham S
    Med J Aust; 1988 Oct; 149(8):417-9. PubMed ID: 3173203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Skin patch and vaginal ring versus combined oral contraceptives for contraception.
    Lopez LM; Grimes DA; Gallo MF; Stockton LL; Schulz KF
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD003552. PubMed ID: 23633314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparing for long-acting PrEP delivery: building on lessons from oral PrEP.
    Celum C; Grinsztejn B; Ngure K
    J Int AIDS Soc; 2023 Jul; 26 Suppl 2(Suppl 2):e26103. PubMed ID: 37439077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study.
    Matthews LT; Atukunda EC; Owembabazi M; Kalyebera KP; Psaros C; Chitneni P; Hendrix CW; Marzinke MA; Anderson PL; Isehunwa OO; Hurwitz KE; Bennett K; Muyindike W; Bangsberg DR; Haberer JE; Marrazzo JM; Bwana MB
    PLoS Med; 2023 Feb; 20(2):e1004088. PubMed ID: 36795763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prospective study of oral pre-exposure prophylaxis initiation and adherence among young women in KwaZulu-Natal, South Africa.
    Mansoor LE; Lewis L; Naicker CL; Harkoo I; Dawood H; Naidoo K; Gengiah TN; Samsunder N; Beesham I; Abdool Karim SS; Abdool Karim Q
    J Int AIDS Soc; 2022 Jul; 25(7):e25957. PubMed ID: 35785472
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unmet Need for Contraception Among Female Sex Workers Initiating Oral Pre-Exposure Prophylaxis for HIV Prevention During Kenya's National Scale-Up: Results From a Programmatic Surveillance Study.
    Kamau M; Musau A; Were D; Waruguru G; Kabue M; Mutegi J; Plotkin M; Reed J
    Front Glob Womens Health; 2021; 2():747784. PubMed ID: 35265940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. United States family planning providers' knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey.
    Seidman D; Carlson K; Weber S; Witt J; Kelly PJ
    Contraception; 2016 May; 93(5):463-9. PubMed ID: 26772906
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Provision of the progestogen-only pill by community pharmacies as bridging contraception for women receiving emergency contraception: the Bridge-it RCT.
    Cameron ST; Glasier A; McDaid L; Radley A; Patterson S; Baraitser P; Stephenson J; Gilson R; Battison C; Cowle K; Vadiveloo T; Johnstone A; Morelli A; Goulao B; Forrest M; McDonald A; Norrie J
    Health Technol Assess; 2021 May; 25(27):1-92. PubMed ID: 33949940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Testing the Effectiveness and Cost-Effectiveness of a Combination HIV Prevention Intervention Among Young Cisgender Men Who Have Sex With Men and Transgender Women Who Sell or Exchange Sex in Thailand: Protocol for the Combination Prevention Effectiveness Study.
    Wirtz AL; Weir BW; Mon SHH; Sirivongrangson P; Chemnasiri T; Dunne EF; Varangrat A; Hickey AC; Decker MR; Baral S; Okanurak K; Sullivan P; Valencia R; Thigpen MC; Holtz TH; Mock PA; Cadwell B; Adeyeye A; Rooney JF; Beyrer C;
    JMIR Res Protoc; 2020 Jan; 9(1):e15354. PubMed ID: 32012113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.